You Min Kim

You Min Kim

Auto-generated profile, based on publicly available information

You Min Kim

Department of Pediatrics, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2025 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
JJJi Eun Jeong
Ji Eun Jeong
YKYou Min Kim
You Min Kim
NLNa Won Lee
Na Won Lee
GKGyeong Nam Kim
Gyeong Nam Kim
JBJisuk Bae
Jisuk Bae
JKJin-Kyung Kim
Jin-Kyung Kim
Background: Early development is characterized by considerable variability.Purpose: This study aimed to examine the stability of developmental classifications using the revised Korean Developmental Screening Test (K-DST) in healthy term infants aged 4–6 and 10–12 months.Methods: Data were obtained from the Korean Children’s Environmental Health Study, a nationwide prospective birth cohort. Sixty-nine healthy term infants (26 boys, 43 girls) underwent serial K-DST assessments at 4–6 and 10–12 months of age, between August 2017 and December 2019Results: At 4–5 months, over 50% of infants were categorized in the ≥-1 standard deviation (SD) group, with the lowest prevalence in the gross motor domain (52.7%). Seven infants (10.1%) scored below -2 SD in at least one domain, most commonly in gross and fine motor domains (7.3%). At 10–12 months, over 70% of infants scored in the ≥-1 SD group, except in the language domain. Six infants (9.5%) scored below -2 SD in at least one domain, (cognition 4.8%, language 3.2%, gross motor 3.2%). Serial follow-up showed significant improvement, with many infants moving to the ≥-1 SD group, particularly in the gross motor domain (33.3%). Of the seven infants scoring below -2 SD at 4–5 months, only two remained in this category at 10–12 months.Conclusion: Infants scoring below -2 SD on the revised K-DST 4–5 months questionnaire, especially in the gross motor domain, should undergo close monitoring and repeated evaluations in the absence of neurological abnormalities or developmental red flags.

30 June 2024 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
NLNa-Won Lee
Na-Won Lee
YKYou-Min Kim
You-Min Kim
YKYoung-Hwan Kim
Young-Hwan Kim
SKSeok-Jin Kang
Seok-Jin Kang
KJKyung Mi Jang
Kyung Mi Jang
JKJin-Kyung Kim
Jin-Kyung Kim
Purpose: Children with comorbidities have a higher risk of severe, coronavirus disease 2019 (COVID-19). This study investigated the clinical features and outcomes of COVID-19 in children and adolescents with diabetes between January and March 2022.Methods: We retrospectively reviewed the medical records of 123 children and adolescents (73 with type 1 diabetes and 50 with type 2 diabetes, 59 males and 64 females) aged <18 years who had been diagnosed with diabetes. Data were collected from 7 academic medical centers in Daegu, South Korea.Results: Thirty-five children with diabetes were diagnosed with COVID-19 (18 with type 1 and 17 with type 2 diabetes). Eighteen of the 35 children with diabetes and COVID-19 and 50 of the 88 children with diabetes alone received a COVID-19 vaccination. No significant differences were observed between patients with diabetes and COVID-19 and patients with diabetes alone in the type of diabetes diagnosed, sex, age, body mass index, hemoglobin A1c, or vaccination status. All children with diabetes and COVID-19 had mild clinical features and were safely managed in their homes. Fourteen children had a fever of 38℃ or higher that lasted for more than 2 days, 11 of whom were not vaccinated (p=0.004). None experienced post-COVID-19 conditions.Conclusion: All children and adolescents with pre-existing diabetes had mild symptoms of COVID-19 due to low disease severity, high vaccination rates, uninterrupted access to medical care, and continuous glucose monitoring. Unvaccinated children with diabetes who experienced COVID-19 presented with higher and more frequent fevers compared to vaccinated children.

30 June 2025 in Journal of Genetic Medicine
Verified
Journal Article
Open access
PDF file
YKYou Min Kim
You Min Kim
YKYounghyun Kim
Younghyun Kim
JKJin-Kyung Kim
Jin-Kyung Kim
You Min Kim, Young Hyun Kim, and Jin Kyung Kim. J Genet Med 2025;22:29-35. https://doi.org/10.5734/JGM.2025.22.1.29

30 April 2025 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
YKYou-Min Kim
You-Min Kim
JKJin-Kyung Kim
Jin-Kyung Kim
To the editor, Constitutional monosomy of part of the short arm of chromosome 9 (chromosome 9p deletion syndrome, OMIM #158170) results in a rare, complex syndromic condition characterized by developmental delay, craniofacial dysmorphism, and multiple congenital anomalies [1-3]. Variability in clinical features may be due to differences in the extent of deletion and haploinsufficiency of specific genes. The genotype-phenotype correlation is unclear due to frequent additional chromosomal rearrangements and inconsistent molecular characterization. Gene disruption within the affected region may reveal recessive traits, contributing to the complex presentation [2]. Congenital hyperinsulinism (CHI) occurs in less than 10% of patients with chromosome 9p deletion syndrome. Its course can be variable, it may require several years of treatment, and the genetic mechanism underlying dysregulated insulin secretion remains unidentified [4-6]. Distal duplication of 14q is rare and is characterized by variable clinical features, including developmental delay, growth retardation, low birth weight, hypotonia, short stature, microcephaly, facial dysmorphism, spasticity, and hyperreflexia; brain, cardiac, digital, and skeletal abnormalities are also likely [7-9]. We present a rare case of CHI in an infant with a karyotype of 46,XX,der(9)t(9p;14q) (p23;q32.2). An 8-month-old female patient was referred to our department for hypoglycemia evaluation. She was the first child born to a 40-year-old mother via cesarean section at 41 weeks of gestation. Her mother had no history of gestational diabetes or other medical conditions, nor did she take any medications during pregnancy. There was no history of diabetes in her father or in three generations of her family. The patient's birth weight, length, and head circumference were 2,990 g (10th-25th percentile), 48 cm (10th-25th percentile), and 35 cm (25th percentile), respectively. After birth, she was admitted to the neonatal intensive care unit because of respiratory failure, hypotonia, cleft palate, and dysmorphic features. Intermittent nasal positive-pressure ventilation was administered immediately after admission because of tachypnea and mild chest retraction. On the first day of life (DOL 1), initial blood glucose level was less than 20 mg/dL. She developed pneumomediastinum with persistent pulmonary hypertension (PPHN). Continuous glucose infusion (glucose infusion rate [GIR], 11 mg/kg/min) dopamine, dobutamine, milrinone, inhaled prostacyclin for PPHN, and intravenous hydrocortisone (5 mg/kg/day) were administered due to PPHN and the possibility of relative adrenal insufficiency. On DOL 2, glucose level reached 29 mg/dL, and a detectable serum insulin level of 93.6 μU/mL, undetectable ketone bodies (0.3 mmol/L), and a normal ammonia level of 51 μmol/L were observed. Echocardiography revealed a mild atrial septum defect, nearly closing the patent ductus arteriosus, and mild septal hypertrophy. Brain magnetic resonance imaging showed a thinning of the corpus callosum, and small T1 hyperintensity in the left frontal deep white matter, suggesting a small hemorrhagic lesion. Karyotyping revealed 46,XX,add(9)(p23). Chromosome microarray analysis (Affymetrix CytoScan 750K Array, Thermo Fisher Scientific, Santa Clara, CA, USA) with human genomic reference sequence GRCh37/hg19 revealed an approximately 10-Mbp deletion at 9p24.3p23, classified as a pathogenic copy number variant (CNV), an 860-kbp duplication at 14q32.2, considered a variant of uncertain significance, and a 9.8-Mbp duplication at 14q32.2q32.33, also classified as a pathogenic CNV (Fig. 1). The patient's karyotype was considered

30 May 2025 in International Journal of Thyroidology
Verified
Journal Article
Open access
PDF file
NLNa Won Lee
Na Won Lee
YKYou Min Kim
You Min Kim
JKJin-Kyung Kim
Jin-Kyung Kim
Na Won Lee, You Min Kim and Jin Kyung Kim. Int J Thyroidol 2025;18:96-101. https://doi.org/10.11106/ijt.2025.18.1.96